What is PFE's current stock price?

As of now, PFE is trading at $25.04, with a daily change of -0.08%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

PFE Stock Analysis & IQ Rating | Pfizer

PFE

Pfizer

$25.04

-$0.02 | -0.08%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$27.69

MKT CAP

$142.37B

52W Low

$20.92

VOL

$46.63M

P/E Ratio

14.55

AVG VOL

$71.41M

RSI

46.13

TREND

Sideways

PFE Stock IQ

Login to see Pfizer (PFE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

PFE Target Price

Login to display

Strengths

PFE Rewards

Earnings are forecast to grow

PFE Rewards

Trading below its fair value

PFE Rewards

Upgraded on attractively valued

PFE Rewards

Investors confidence is positive

PFE Price Performance

$25.04 (0.00%)

$23.6 (+6.10%)

$23.81 (+5.17%)

$26.59 (-5.83%)

1year

6month

3month

1month

PFE Risk Level

PFE has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Low

LOW

HIGH

PFE Analysts Opinion

PFE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

PFE Analysts Opinion

PFE Analysts opinion is positive but there was a setback from the past 3 months

PFE Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

72%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

29%

50%

81%

PFE Street Sentiment

PFE Street Sentiment is bullish and have positive views on the near-term outlook

PFE Performance Sentiment

Sentiments overview associated with PFE events and the stock performance.

72%

21%

Positive

Negative

52 out of 72
events present

15 out of 72
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$25.04

Resistance
Price

$24.40

Current Price Range

$26.43

Show methods +

Linked to PFE

IQ

Close Price

Change

NVS

4.27

135.27

+0.18%

SNY

4.02

47.99

-0.31%

AZN

4.31

90.61

+0.83%

MRK

4.03

100.69

+1.49%

NVO

3.91

47.61

-0.32%

PFE Latest Analysis +

Pfizer Plays Catchup In Obesity Market Licenses Weight-loss Drug From Fosun. Playing catch-up in the anti-obesity business Pfizer has bought global rights to an oral weight-loss drug from Fosun Pharma in another big licensing deal

Key Takeaways:With the drug still at an early stage of development Pfizer has negotiated an opt-out clause in case trials do not go to planFosun Pharma'.s revenues from innovative drugs jumped 18.09% in the first three quarter

Today

$25.04 | -0.08%

Activity

Morgan Stanley Maintains Pfizer (PFE) Equal-Weight Recommendation. Fintel reports that on December 17 2025 Morgan Stanley maintained coverage of Pfizer (NYSE:PFE) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 18.46% Upside

Today

$25.04 | -0.08%

Potential

Rating

Astellas Reports Positive Phase 3 EV-304 Results For PADCEV Combo In Muscle-Invasive Bladder Cancer . (RTTNews) - Astellas Pharma Inc. and Pfizer Inc. announced positive topline results from the Phase 3 EV-304 clinical trial (KEYNOTE-B15) evaluating PADCEV (enfortumab vedotin) a Nectin-4 directed antibody-drug conjugate in combination with Keytruda®. (pembrolizumab) a PD-1 inh

Today

$25.04 | -0.08%

Activity

Pfizer Inc (PFE) Rating Steady Amid Neutral Market Outlook and Pipeline Progress. We recently compiled a list of 9 Most Undervalued Pharma Stocks to Buy Right Now. Pfizer Inc tops our list for being one of the most undervalued pharmaceutical stocks. On Friday December 12 2025 The Fly reported that Morgan Stanley maintained its Hold (Equal‑Weight) rating on PFE. while lowering the price target to $28 from [….]

Wed Dec 17, 2025

$25.04 | -1.92%

Potential

Pfizer: Ignoring The Dead Cat Bounce.

Wed Dec 17, 2025

$25.04 | -1.92%

Momentum

FDA Approves Brain Tumor Warning For Pfizers Depo-Provera Amid Lawsuit. The United States Food and Drug Administration (FDA) has approved a label change for ) Depo-Provera contraceptive injection adding a warning about the risk of meningioma a type of brain tumor as the company faces mounting legal challenges over the .The decision affects two injectable versions of the drug — Depo-Provera CI and Depo-Subq Provera 104.The label comes as the pharmaceutical giant is defending itself against lawsu

Wed Dec 17, 2025

$25.04 | -1.92%

Activity

Pfizer Issues Soft 2026 View: What Does It Mean for the Stocks Future?. PFEs soft 2026 outlook spooks investors with revenue and EPS guidance trailing expectations as COVID-19 demand fades and patent losses mount.

Wed Dec 17, 2025

$25.04 | -1.92%

Activity

Guggenheim maintains Buy rating on Pfizer stock sets $35 price target.

Wed Dec 17, 2025

$25.04 | -1.92%

Rating

Stock Market Today Dec. 16: Pfizer Falls After Cutting 2025 Revenue Forecast. Pfizer (NYSE:PFE) which develops and sells biopharmaceutical products worldwide closed todays session (Dec. 16) at $25.53 down 3.41%. Trading volume reached 108.1 million shares almost 60% above its three-month average.

Tue Dec 16, 2025

$25.55 | -3.41%

Momentum

Pfizer leads COVID-19 vaccine peers lower after revamped guidance.

Tue Dec 16, 2025

$25.55 | -3.41%

Momentum

Potential

FAQ About PFE Stock Insights

What is PFE current stock price?

What are PFE stock strengths?

What is PFE Risk Level?

What is PFE market cap and volume?

What is PFE current Stock IQ?

Should I buy PFE stock right now?

Is PFE a Strong Buy right now?

What does a 'Strong Buy' rating mean for PFE?

What does a 'Strong Sell' rating mean for PFE?

What factors influence PFE's Stock IQ?

Explore our PFE Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored PFE Stock Strategies
Effective Risk Management

FIND US ON

Receive our PFE Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

PFE

Pfizer

Current Price

$25.04

-$0.02 | -0.08%

52W High

$27.69

MKT CAP

$142.37B

52W Low

$20.92

VOL

$46.63M

P/E Ratio

14.55

AVG VOL

$71.41M

RSI

46.13

TREND

Sideways

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

PFE Rewards

Earnings are forecast to grow

PFE Rewards

Trading below its fair value

PFE Rewards

Upgraded on attractively valued

PFE Rewards

Investors confidence is positive

Linked to PFE

Symbol

IQ

Close

Change

NVS

4.27

135.27

+0.18%

SNY

4.02

47.99

-0.31%

AZN

4.31

90.61

+0.83%

MRK

4.03

100.69

+1.49%

NVO

3.91

47.61

-0.32%

PFE Price Performance

$25.04 (0.00%)

$23.6 (+6.10%)

$23.81 (+5.17%)

$26.59 (-5.83%)

1year

6month

3month

1month

PFE Analysts Opinion

PFE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

PFE Analysts Opinion

PFE Analysts opinion is positive but there was a setback from the past 3 months

PFE Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

72%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

29%

50%

81%

PFE Street Sentiment

PFE Street Sentiment is bullish and have positive views on the near-term outlook

PFE Risk Level

PFE has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Low

LOW

HIGH

PFE Performance Sentiment

Sentiments overview associated with PFE events and the stock performance.

72%

21%

Positive

Negative

52 out of 72
events present

15 out of 72
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$25.04

Resistance
Price

$24.40

Current Price Range

$26.43

Show methods +

PFE Stock IQ

Login to unlock Pfizer (PFE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

PFE Latest Analysis

Pfizer Plays Catchup In Obesity Market Licenses Weight-loss Drug From Fosun. Playing catch-up in the anti-obesity business Pfizer has bought global rights to an oral weight-loss drug from Fosun Pharma in another big licensing deal

Key Takeaways:With the drug still at an early stage of development Pfizer has negotiated an opt-out clause in case trials do not go to planFosun Pharma'.s revenues from innovative drugs jumped 18.09% in the first three quarter

Today

$25.04 | -0.08%

Activity

Morgan Stanley Maintains Pfizer (PFE) Equal-Weight Recommendation. Fintel reports that on December 17 2025 Morgan Stanley maintained coverage of Pfizer (NYSE:PFE) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 18.46% Upside

Today

$25.04 | -0.08%

Potential

Rating

Astellas Reports Positive Phase 3 EV-304 Results For PADCEV Combo In Muscle-Invasive Bladder Cancer . (RTTNews) - Astellas Pharma Inc. and Pfizer Inc. announced positive topline results from the Phase 3 EV-304 clinical trial (KEYNOTE-B15) evaluating PADCEV (enfortumab vedotin) a Nectin-4 directed antibody-drug conjugate in combination with Keytruda®. (pembrolizumab) a PD-1 inh

Today

$25.04 | -0.08%

Activity

Pfizer Inc (PFE) Rating Steady Amid Neutral Market Outlook and Pipeline Progress. We recently compiled a list of 9 Most Undervalued Pharma Stocks to Buy Right Now. Pfizer Inc tops our list for being one of the most undervalued pharmaceutical stocks. On Friday December 12 2025 The Fly reported that Morgan Stanley maintained its Hold (Equal‑Weight) rating on PFE. while lowering the price target to $28 from [….]

Wed Dec 17, 2025

$25.04 | -1.92%

Potential

Pfizer: Ignoring The Dead Cat Bounce.

Wed Dec 17, 2025

$25.04 | -1.92%

Momentum

FDA Approves Brain Tumor Warning For Pfizers Depo-Provera Amid Lawsuit. The United States Food and Drug Administration (FDA) has approved a label change for ) Depo-Provera contraceptive injection adding a warning about the risk of meningioma a type of brain tumor as the company faces mounting legal challenges over the .The decision affects two injectable versions of the drug — Depo-Provera CI and Depo-Subq Provera 104.The label comes as the pharmaceutical giant is defending itself against lawsu

Wed Dec 17, 2025

$25.04 | -1.92%

Activity

Pfizer Issues Soft 2026 View: What Does It Mean for the Stocks Future?. PFEs soft 2026 outlook spooks investors with revenue and EPS guidance trailing expectations as COVID-19 demand fades and patent losses mount.

Wed Dec 17, 2025

$25.04 | -1.92%

Activity

Guggenheim maintains Buy rating on Pfizer stock sets $35 price target.

Wed Dec 17, 2025

$25.04 | -1.92%

Rating

Stock Market Today Dec. 16: Pfizer Falls After Cutting 2025 Revenue Forecast. Pfizer (NYSE:PFE) which develops and sells biopharmaceutical products worldwide closed todays session (Dec. 16) at $25.53 down 3.41%. Trading volume reached 108.1 million shares almost 60% above its three-month average.

Tue Dec 16, 2025

$25.55 | -3.41%

Momentum

Pfizer leads COVID-19 vaccine peers lower after revamped guidance.

Tue Dec 16, 2025

$25.55 | -3.41%

Momentum

Potential

Discover PFE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of PFE. We're here to help you make informed investment decisions today.

FIND US ON

Receive our PFE Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

PFE Stock trends

PFE Stock performance

PFE Stock analysis

PFE investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

PFE Stock Analysis & IQ Rating | Pfizer

PFE Stock IQ

PFE Target Price

PFE Risk Level

PFE Analysts Opinion

PFE Street Sentiment

PFE Performance Sentiment

Technical Price Levels

Explore our PFE Stock insights

Receive our PFE Daily Alerts

PFE Street Sentiment

PFE Risk Level

Technical Price Levels

Discover PFE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of PFE. We're here to help you make informed investment decisions today.

Receive our PFE Daily Alerts

PFE Runner Alarm